.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Army
Accenture
Cipla
Healthtrust
Chubb
Novartis
AstraZeneca
Dow
Baxter

Generated: July 23, 2017

DrugPatentWatch Database Preview

NEOMYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Neomycin , and what generic Neomycin alternatives are available?

Neomycin is a drug marketed by Pharmafair, X Gen Pharms, Watson Labs, Bausch And Lomb, Perrigo Co Tennessee, Akorn, Alcon Pharms Ltd, Ipharm, Amring Pharms, Sandoz Inc, Teva, Lannett, Lannett Holdings Inc, Bristol Myers Squibb, Oman Pharm Products, Roxane, Lilly, Sandoz, Fougera, and Pharmaderm. and is included in forty-two NDAs.

The generic ingredient in NEOMYCIN is neomycin sulfate; triamcinolone acetonide. There are eighteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.

Summary for Tradename: NEOMYCIN

Patents:0
Applicants:20
NDAs:42
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEOMYCIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm
NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
neomycin sulfate; triamcinolone acetonide
CREAM;TOPICAL062595-001Jul 21, 1986DISCNNoNo► Subscribe► Subscribe
Bausch And Lomb
NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC064055-001Oct 30, 1995DISCNNoNo► Subscribe► Subscribe
Oman Pharm Products
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL065468-001Mar 29, 2010AARXNoNo► Subscribe► Subscribe
Pharmafair
NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN
gramicidin; neomycin sulfate; polymyxin b sulfate
SOLUTION/DROPS;OPHTHALMIC062383-001Aug 31, 1982DISCNNoNo► Subscribe► Subscribe
Roxane
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL062173-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Mallinckrodt
Federal Trade Commission
US Department of Justice
Cantor Fitzgerald
Julphar
US Army
Queensland Health
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot